We are live on ! Find out more
IMDZ

Immune Design Corp.
IMDZ

Delisted

IMDZ was delisted on the 1st of April, 2019.

0 hedge funds and large institutions have $0 invested in Immune Design Corp. in 2019 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 66 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 680 (-68)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

100% less capital invested

Capital invested by funds: $165M → $0 (-$165M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 66

Holders
Holders Change
-68
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
Closed
66
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
PS
1
Peter Svennilson
-$38.9M -6,642,942 Closed
AAM
2
Alpine Associates Management
Florida
-$14M -2,400,000 Closed
BlackRock
3
BlackRock
New York
-$13.1M -2,231,444 Closed
TAL
4
TIG Advisors LLC
New York
-$11.8M -2,016,916 Closed
Vanguard Group
5
Vanguard Group
Pennsylvania
-$8.9M -1,521,404 Closed
GF
6
Gabelli Funds
New York
-$7.67M -1,311,069 Closed
SAM
7
Sandell Asset Management
New York
-$7.61M -1,300,500 Closed
BCM
8
Beryl Capital Management
California
-$6.3M -1,076,894 Closed
Renaissance Technologies
9
Renaissance Technologies
New York
-$6.04M -1,031,905 Closed
Man Group
10
Man Group
United Kingdom
-$5.85M -1,000,000 Closed
Dimensional Fund Advisors
11
Dimensional Fund Advisors
Texas
-$3.68M -629,658 Closed
WIC
12
Water Island Capital
New York
-$3.56M -608,000 Closed
DAM
13
DLD Asset Management
New York
-$3.51M -600,030 Closed
State Street
14
State Street
Massachusetts
-$3.49M -597,011 Closed
GCIA
15
Gabelli & Co Investment Advisers
New York
-$3.46M -591,650 Closed
Geode Capital Management
16
Geode Capital Management
Massachusetts
-$2.47M -421,833 Closed
Northern Trust
17
Northern Trust
Illinois
-$2.04M -348,282 Closed
OAC
18
OMERS Administration Corp
Ontario, Canada
-$1.84M -304,000 Closed
Two Sigma Advisers
19
Two Sigma Advisers
New York
-$1.72M -294,400 Closed
JP Morgan Chase
20
JP Morgan Chase
New York
-$1.68M -286,375 Closed
OAM
21
Oxford Asset Management
United Kingdom
-$1.58M -270,803 Closed
D.E. Shaw & Co
22
D.E. Shaw & Co
New York
-$1.5M -257,007 Closed
PAM
23
Panagora Asset Management
Massachusetts
-$1.31M -224,038 Closed
QOP
24
Quinn Opportunity Partners
Virginia
-$1.26M -215,000 Closed
Two Sigma Investments
25
Two Sigma Investments
New York
-$1.15M -196,624 Closed

IMDZ Hedge Fund Activity: Q2 2019 in Review

0 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Immune Design Corp. (IMDZ) for Q2 2019, worth a combined $0 — down 100% from $165M a quarter earlier.

Sellers outnumbered buyers: 66 funds closed out of IMDZ and 0 opened new positions — a net loss of 66 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Peter Svennilson, exiting entirely with an estimated $38.9M sold.

  • 0 institutional investors held Immune Design Corp. (IMDZ) as of Q2 2019, down from 68 in Q1 2019.
  • Funds reported $0 of Immune Design Corp. stock for Q2 2019, down 100% quarter-over-quarter.
  • 0 funds opened new Immune Design Corp. positions in Q2 2019 and 66 closed out, a net change of -66 holders.
  • The largest Immune Design Corp. seller in Q2 2019 was Peter Svennilson, an estimated $38.9M sold.

Based on aggregated 13F filings for Q2 2019.